PIEZO1 and Bardet-Biedl syndrome: To probe the specificity of nanoparticle labelling, we immunostained nanoparticles bound to cells transfected with Piezo1-BBS constructs or wild-type Piezo1, which does not contain any BBS, and compared their near-membrane fluorescence.